6533b82cfe1ef96bd128fb7d

RESEARCH PRODUCT

HBV virological suppression: still not enough to save from hepatocellular carcinoma. A case report on a 15-year, real-life story

T. PrestileoFrancesco Di LorenzoA. SanfilippoClaudia ImburgiaGiuseppe CabibboSalvatore Corrao

subject

AdultMaleCarcinoma HepatocellularCoinfectionMedicine (all)Liver NeoplasmsHIVVirological suppressionHIV InfectionsAntiviral AgentsMedication AdherenceHepatitis B ChronicHBVHumansHCC

description

Among HIV-infected patients worldwide, 2-4 million are chronically infected with HBV. We report a 15-year, real-life story of a patient with HBV-HIV coinfection, who developed HCC despite high treatment adherence and complete viral suppression. The aim of our report is to alert the infectious diseases community to monitor the possible development of HCC regardless of high treatment adherence and complete viral suppression.

10.1701/2745.27990https://pubmed.ncbi.nlm.nih.gov/28901347